Planning for a New Era: Commercial Strategy under the Lens of Public Scrutiny
Meet with us at the 38th annual J.P. Morgan Healthcare Conference, January 13-16, 2020
Meet with us at the RARE Patient Advocacy Summit, September 18-20, 2019
Meet with us at the 37th annual J.P. Morgan Healthcare Conference, January 6-9, 2019
Meet with us at the 8th annual World Orphan Drug Congress in Washington, D.C., April 25-27, 2018
Meet with us at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco January 8-11, 201
Diligentia President, Joff Masukawa, will serve as a panelist at the Virginia Bioscience Commerciali
Diligentia President, Joff Masukawa, will serve as a panelist in this evening's Johns Hopkins Un
What Does the Government Investigation on the Orphan Drug Program Mean for Drug Manufacturers?
The Impact of the American Health Care Act on Rare Disease Patients
